Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas
26 July 2011 | By Merck
Merck and Astellas US LLC have entered into an agreement...
List view / Grid view
26 July 2011 | By Merck
Merck and Astellas US LLC have entered into an agreement...
25 July 2011 | By The Scott Partnership
22nd Annual International Light Scattering Colloquium announced...
25 July 2011 | By Roche
Roche has been awarded an exclusive contract by the National Health Laboratory Services (NHLS)...
25 July 2011 | By College Hill Ltd
LEUKOCARE AG, announced the signing of a cooperation agreement with Sanofi Pasteur...
22 July 2011 | By kdm communications ltd
Expansion of the CompoZr® Oncology Disease Model portfolio...
22 July 2011 | By Sanofi
Sanofi is pleased to announce the appointment of Greg Irace, to the newly created role of Senior Vice President, Global Services...
22 July 2011 | By Novartis
The Committee for Medicinal Products for Human Use of the EMA adopted a positive opinion for Afinitor® (everolimus) tablets...
22 July 2011 | By Takeda Pharmaceutical Company Limited
The EMA has recommended changes to the label of pioglitazone-containing medicines...
21 July 2011 | By Cephalon, Inc.
The FDA approved the Risk Evaluation and Mitigation Strategy for FENTORA® & ACTIQ®...
21 July 2011 | By GlaxoSmithKline
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended an update to the product label, Pandemrix...
21 July 2011 | By Bristol-Myers Squibb
Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company...
21 July 2011 | By Merck
Merck & Co., Inc., and Simcere announced the signing of a framework agreement to establish a joint venture...
21 July 2011 | By AD Communications Ltd
Brecon Pharmaceuticals, has appointed Charles Evans to the role of operations director...
21 July 2011 | By The Scott Partnership
Novozymes Biopharma, received the 2011 NEP Business Award...
21 July 2011 | By
The Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. FDA recommended the approval of REMICADE® (infliximab)...